Management of common femoral artery occlusive disease: the current gap in the evidence and future perspectives
dc.contributor.author | Messeder, Sarah | |
dc.contributor.author | Musto, Liam | |
dc.contributor.author | Saratzis, Athanasios | |
dc.date.accessioned | 2024-06-26T09:43:19Z | |
dc.date.available | 2024-06-26T09:43:19Z | |
dc.date.issued | 2024-06-18 | |
dc.identifier.citation | Messeder, S. J., Musto, L., & Saratzis, A. (2024). Management of common femoral artery occlusive disease: the current gap in the evidence and future perspectives. The Journal of cardiovascular surgery, 10.23736/S0021-9509.24.13107-2. Advance online publication. https://doi.org/10.23736/S0021-9509.24.13107-2 | en_US |
dc.identifier.other | 10.23736/S0021-9509.24.13107-2 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/18755 | |
dc.description.abstract | The common femoral artery (CFA) is the most common site affected by peripheral artery disease. Due its various anatomical and morphological features, common femoral endarterectomy has long since been the preferred treatment option. However, there are complications associated with common femoral endarterectomy including, but not limited to, surgical site infections, hematoma formation, bleeding, and nerve injury. Unfortunately, this has been further complicated by the ageing population and increasing epidemic of obesity and diabetes mellitus. Within vascular surgery, there has been a rise in use of endovascular techniques for peripheral artery disease. Endovascular repair of the CFA is safe and feasible. One clear advantage is that they can be performed under local or regional anesthesia, thus reducing morbidity. This narrative review seeks to describe the current gap in the evidence and future perspectives in the management of common femoral artery occlusive disease. | |
dc.description.uri | https://www.minervamedica.it/en/journals/cardiovascular-surgery/article.php?cod=R37Y9999N00A24061802 | en_US |
dc.language.iso | en | en_US |
dc.subject | common femoral artery (CFA) | en_US |
dc.subject | common femoral artery occlusive disease | en_US |
dc.title | Management of common femoral artery occlusive disease: the current gap in the evidence and future perspectives | en_US |
dc.type | Article | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
rioxxterms.version | NA | en_US |
rioxxterms.versionofrecord | https:/doi.org/10.23736/S0021-9509.24.13107-2 | en_US |
rioxxterms.type | Journal Article/Review | en_US |
refterms.panel | Unspecified | en_US |
html.description.abstract | The common femoral artery (CFA) is the most common site affected by peripheral artery disease. Due its various anatomical and morphological features, common femoral endarterectomy has long since been the preferred treatment option. However, there are complications associated with common femoral endarterectomy including, but not limited to, surgical site infections, hematoma formation, bleeding, and nerve injury. Unfortunately, this has been further complicated by the ageing population and increasing epidemic of obesity and diabetes mellitus. Within vascular surgery, there has been a rise in use of endovascular techniques for peripheral artery disease. Endovascular repair of the CFA is safe and feasible. One clear advantage is that they can be performed under local or regional anesthesia, thus reducing morbidity. This narrative review seeks to describe the current gap in the evidence and future perspectives in the management of common femoral artery occlusive disease. | en_US |
rioxxterms.funder.project | 94a427429a5bcfef7dd04c33360d80cd | en_US |